ALIVUSBSEAlivus Life Sciences LtdLowNeutral
Announced Fri, 8 May · 12:54 IST

Enclosed please find herewith the details of Earnings Call slated for Friday, May 15, 2026 from 8:30 a.m. to 9:30 a.m. (IST), for your information and record.

Board & Shareholder Meetings View source PDF

ALIVUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.8%1-day move
₹1117.10
prior close
₹1126.10
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.1+0.1-0.3+0.8-1.2-2.7-4.6-7.3-4.9-6.2-10.6+1.6
Up moveDown movePending
AI summary

Alivus Life Sciences Ltd (formerly Glenmark Life Sciences Ltd) has notified exchanges about an earnings call scheduled for Friday, May 15, 2026, from 8:30 a.m. to 9:30 a.m. IST. The call will cover the company's Q4 and full-year FY2025-26 financial performance. The company has provided universal dial-in numbers (India), international toll-free numbers across major countries, and toll numbers for live participation. EY representatives Diwakar Pingle and Runjhun Jain are listed as contacts for clarifications. This is a routine regulatory intimation filed with BSE (Scrip Code: 543322) and NSE (Scrip Name: ALIVUS).

Likely market impact

This is a standard investor communication with no immediate impact on shareholders. The actual earnings disclosure during the call will be the material event for investors.